Mersana Therapeutics
MRSN
MRSN
48 hedge funds and large institutions have $70M invested in Mersana Therapeutics in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
65% less capital invested
Capital invested by funds: $198M → $70M (-$128M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
48
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.24M | |
| 2 | +$1.37M | |
| 3 | +$764K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$434K |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
+$348K |
Top Sellers
| 1 | -$7.19M | |
| 2 | -$4.96M | |
| 3 | -$1.36M | |
| 4 |
Millennium Management
New York
|
-$1.33M |
| 5 |
BlackRock
New York
|
-$995K |